# Ablation With Transcatheter Edge-to-edge Repair for Atrial Functional Mitral Regurgitation and Atrial Fibrillation

Study · id `cardio:ct-nct07744035` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07744035](<https://clinicaltrials.gov/study/NCT07744035>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07744035

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 384 participants.

## Technical summary

Registry record NCT07744035. Randomized; no masking; primary purpose treatment. Start 2026-09-01 (anticipated); primary completion 2028-09-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 384 participants (planned count; ClinicalTrials.gov record NCT07744035, source copy `cardio:ctgov-nct07744035-2026-08-04`, retrieved 2026-10-26)
- Planned start: 2026-09-01 (anticipated) (ClinicalTrials.gov record NCT07744035, source copy `cardio:ctgov-nct07744035-2026-08-04`, retrieved 2026-10-26)
- Primary completion: 2028-09-01 (anticipated) (ClinicalTrials.gov record NCT07744035, source copy `cardio:ctgov-nct07744035-2026-08-04`, retrieved 2026-10-26)
- Completion: 2029-09-01 (anticipated) (ClinicalTrials.gov record NCT07744035, source copy `cardio:ctgov-nct07744035-2026-08-04`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07744035-2026-08-04`, retrieved 2026-10-26)

## The registry's words

- Brief title: Ablation With Transcatheter Edge-to-edge Repair for Atrial Functional Mitral Regurgitation and Atrial Fibrillation
- Acronym: ATTRACTION
- Condition: Atrial Functional Mitral Regurgitation
- Condition: Atrial Fibrillation (AF)
- Intervention (Device): Transcatheter edge to edge repair
- Intervention (Procedure): Catheter ablation
- Lead sponsor: Mao Chen
- Lead sponsor class: OTHER
- Collaborator: Abbott
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as a collaborator: Abbott (`cardio:abbott`)

## Provenance

Content hash: f624adb7bcba7711cdc4404094a09259bf05e32be04e14e611269f566eacb408
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
